Диссертация (1141140), страница 37
Текст из файла (страница 37)
– P. 341-345.224321. Morris, R.G. Developments of a water-maze procedure for studying spatiallearning in the rat // J. Neurosci. Methods. – 1984. – Vol. 11, № 1. – P. 47–60.322. Mrak, R. E. Glia and their cytokines in progression of neurodegeneration / R. E.Mrak, W. S. Griffin // Neurobiol.
Aging. – 2005. – Vol. 26, № 3. – P. 349-354.323.Muindi, F.The acute effects of light on murine sleep during the dark phase:importance of melanopsin for maintenance of light-induced sleep /F.Muindi,J.M. Zeitzer,D. Colas [et al.] // Eur. J. Neurosci. – 2013. – Vol. 37, № 11. – Р. 1727-1736.324. Musazzi, L. Functional and Structural Remodeling of Glutamate Synapses inPrefrontal and Frontal Cortex Induced by Behavioral Stress / L. Musazzi, G.
Treccani,M. Popoli // Front. Psychiatry. – 2015. – Vol. 6. – P. 60.325. Musshoff, U. Melatonin receptors in rat hippocampus: molecular and functionalinvestigations / U. Musshoff, D. Riewenherm, E. Berger[et al.] // Hippocampus. – 2002.– Vol. 12. – P. 165–173.326.Mustard, C. Work injury risk by time of day in two population-based datasources / C.
Mustard, A. Chambers, C. McLeod [et al.] // Occup. Environ Med. – 2013.– Vol. 70, № 1. – P. 49-56.327. Nakanishi-Ueda, T. Blue LED light exposure develops intracellular reactiveoxygen species, lipid peroxidation, and subsequent cellular injuries in cultured bovineretinal pigment epithelial cells / T. Nakanishi-Ueda, H.J. Majima, K. Watanabe [et al.] //Free Radic.
Res. – 2013. – Vol. 47, № 10. – P. 774-780.328. Naskar, A. Melatonin enhances L-DOPA therapeutic effects, helps to reduce itsdose,andprotectsdopaminergicneuronsin1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice / A. Naskar, V. Prabhakar, R. Singh[et al.] // J. Pineal Res. – 2015. –58, № 3. – P. 262-274.329. Navara, K.J. The dark side of light at night: physiological, epidemiological, andecological consequences / K.J. Navara, R.J. Nelson // J.
Pineal Res. – 2007. – Vol. 43,№ 3. – P. 215-224.330. Navarro-Alarcón, M. Melatonin and metabolic regulation: a review / M. NavarroAlarcón, F.J. Ruiz-Ojeda, R.M. Blanca-Herrera [et al.] // Food Funct. – 2014. – Vol. 5,№ 11. – P. 2806-2832.225331. Nelson, R.J. Role of melatonin in mediating seasonal energetic and immunologicadaptations / R.J. Nelson, G.E. Demas // Brain. Res. Bull.
– 1997. – Vol. 44, № 4. – P.423–430.332. Newkirk, G.S. Inhibitory inputs tune the light response properties ofdopaminergic amacrine cells in mouse retina / G.S. Newkirk, M. Hoon, R.O. Wong [etal.] // J. Neurophysiol. – 2013. – Vol. 110, № 2. – P. 536-552.333. Nováková, M. Restricted feeding regime affects clock gene expression profilesinthe suprachiasmatic nucleus of rats exposed to constant light / M. Nováková, L.Polidarová, M. Sládek [et al.] // Neuroscience. – 2011.
– Vol. 197. – Р. 65-71.334. Novati, A. Chronically restricted sleep leads to depression-like changes inneurotransmitter receptor sensitivity and neuroendocrine stress reactivity in rats / A.Novati, V. Roman, T. Cetin [et al.] // Sleep. – 2008. – Vol. 31, № 11. – 1579-1585.335. O'Donnell, L.A. Interferon gamma induces protective non-canonical signalingpathways in primary neurons / L.A. O'Donnell, K.M. Henkins, A. Kulkarni [et al.] // J.Neurochem.
–2015. – Vol. 135, № 2. – P. 309-322.336. Oei, N.Y. Stress shifts brain activation towards ventral 'affective' areas duringemotional distraction / N.Y. Oei, I.M. Veer, O.T. Wolf [et al.] // Soc. Cogn. Affect.Neurosci. – 2012. – Vol. 7, № 4. – P. 403-412.337. Ohdo, S. Changing the dosing schedule minimizes the disruptive effects ofinterferon on clock function / S. Ohdo, S. Koyanagi, H. Suyama [et al.] // Nature Med.
–2001. – Vol. 7, № 3. – P. 356–360.338. O’Keefe, J. The hippocampus as a spatial map. Preliminary evidence from unitactivity in the freely-moving rat / J. O’Keefe, J. Dostrovsky // Brain. Res. – 1971. – Vol.34. – P. 171–175.339. Ospeck, M.C. Light-dark cycle memory in the mammalian suprachiasmaticnucleus / M.C.
Ospeck, B. Coffey, D. Freeman // Biophys. J. – 2009. – Vol. 97, № 6. –P. 1513-1524.340. Ostrin, L.A. Pharmacologically Stimulated Pupil and Accommodative Changes inGuinea Pigs / L.A. Ostrin, M.B. Garcia, V. Choh [et al.] // Invest Ophthalmol. Vis. Sci.– 2014. – Vol. 55, № 8.
– P. 5456-5465.226341. Page, H. J. Architectural constraints are a major factor reducing path integrationaccuracy in the rat head direction cell system / H. J. Page, D. Walters, S. M. Stringer //Front Comput Neurosci. – 2015. – Vol. 9. – P. 1-10.342. Paine, N.J. Association of depressive and anxiety symptoms with 24-hour urinarycatecholamines in individuals with untreated high blood pressure / N.J. Paine, L.L.Watkins, J.A.
Blumenthal [et al.] // Psychosom. Med. – 2015. – Vol. 77, № 2. – P. 136144.343. Païzanis, E. Behavioural and neuroplastic effects of the new-generationantidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impairedmice / E. Païzanis, T.
Renoir, V. Lelievre [et al.] // Int. J. Neuropsychopharmacol. –2010. – Vol. 13, №6. – P. 759-774.344. Pan, W. Cytokine transport across the injured blood-spinal cord barrier / W. Pan,A.J. Kastin // Curr. Pharm. Des. – 2008. – Vol. 14, № 16. – P. 1620-1624.345. Pan, A. Rotating night shift work and risk of type 2 diabetes: two prospectivecohort studies in women / A. Pan, E.S.
Schernhammer, Q. Sun [et al.] // PLoS Med. –2011. – Vol. 8, № 12. – P. 1-8.346. Pan, W. Upregulation of the transport system for TNFalpha at the blood-brainbarrier / W. Pan, A.J. Kastin // Archives of Physiology and Biochemistry. – 2001. –Vol. 109, № 4. – P. 350-353.347. Pandi-Perumal, S. R.
Great Challenges to Sleep Medicine: Problems andParadigms / S. R. Pandi-Perumal, D.W. Spence, G.M. Brown [et al.] // Front Neurol. –2010. – Vol. 1. – P. 1-5.348. Pandi-Perumal, S. R. Melatonin: Nature’s mostversatile biological signal? / S. R.Pandi-Perumal, V. Srinivasan, G. J. Maestroni [et al.] // FEBS Journal. – 2006. – Vol.
–273. – P. 2813–2838.349. Pandi-Perumal, S.R. Physiological effects of melatonin: role of melatoninreceptors and signal transduction pathways / S.R. Pandi-Perumal, I. Trakht, V.Srinivasan [et al] // Prog. Neurobiol. – 2008. – Vol. 85, № 3. – P. 335–353.227350.
Pandi-Perumal, S.R. The roles of melatonin and light in the pathophysiology andtreatment of circadian rhythm sleep disorders / S.R. Pandi-Perumal, I. Trakht, D.W.Spence [et al.] // Nat. Clin. Pract. Neurol. – 2008. – Vol. 4, № 8. – P. 436-447.351. Paradies, G. Melatonin, cardiolipin and mitochondrial bioenergetics in health anddisease / G. Paradies, G. Petrosillo, V.
Paradies [et al.] // J. Pineal Res. – 2010. – Vol.48, № 4. – P. 297–310.352. Park, S.Y. Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alphastabilization under hypoxia / S.Y. Park, W.J. Jang, E.Y. Yi [et al.] // J. Pineal Res. –2010. – Vol. 48, № 2.
– P.178-184.353. Pauley, S.M. Lighting for the human circadian clock: recent research indicatesthat lighting has become a public health issue // Medical Hypotheses. – 2004. – Vol. 63.– P. 588–596.354. Paulis, F. Blood pressure modulation and cardiovascular protection by melatonin:potential mechanisms behind / L. Paulis, F.
Simko // Physiol. Res. – 2007. – Vol. 56, №6. – P. 671-684.355. Pawlikowski, M. Effects of six months melatonin treatment on sleep quality andserum concentrations of estradiol, cortisol, dehydroepiandrosterone sulfate, andsomatomedin C in elderly women / M. Pawlikowski, M. Kolomecka, A. Wojtczak [etal.] // Neuro Endocrinol. Lett. – 2002. – Vol. 23, № 1. – P. 17-19.356.
Perreau-Lenz, S. Suprachiasmatic control of melatonin synthesis in rats:inhibitory and stimulatory mechanisms / S. Perreau-Lenz, A. Kalsbeek, M.L. Garidou,[et al.] // Eur. J. Neurosci. – 2003. – Vol. 17, № 2. – P. 221-228.357. Petri, D. Serotonergic interaction between medial prefrontal cortex andmesotelencephalic DA system underlies cognitive and affective deficits inhemiparkinsonian rats / D. Petri, M.A. de Souza Silva, O.Y. Chao [et al.] //Neuroscience.
– 2015. – Vol. 307. – P. 51-63.358. Peschke, E. Melatonin and Pancreatic Islets: Interrelationships betweenMelatonin, Insulin and Glucagon / E. Peschke, I. Bähr, E. Mühlbauer // Int. J. Mol. Sci.– 2013. – Vol. 14, № 4. – P. 6981–7015.228359. Peschke, E. Melatonin and type 2 diabetes - a possible link? / E. Peschke, I.Stumpf, I. Bazwinsky [et al.] // J. Pineal Res. –2007. –Vol. 42, № 4. – Р.350-358.360.
Pevet, P. Melatonin: both master clock output and internal time-giver in thecircadian clocks network / P. Pevet, E. Challet // J. Physiol. Paris. – 2011. – Vol. 105,№ 4-6. – P. 170-182.361. Pezze, M.A. Effects of dopamine D1 modulation of the anterior cingulate cortexin a fear conditioning procedure / M.A. Pezze, H.J. Marshall, A. Domonkos [et al.] //Prog. Neuropsychopharmacol Biol. Psychiatry.
– 2015. – Vol. 65. – P. 60-67.362. Pinheiro, S.P. A prospective study on habitual duration of sleep and incidence ofbreast cancer in a large cohort of women / S.P. Pinheiro, E.S. Schernhammer, S.S.Tworoger [et al.] // Cancer Res. – 2006. – Vol. 66, № 10. – P. 5521-5525.363. Pizarro, J.G. The antiproliferative activity of melatonin in B65 rat dopaminergicneuroblastoma cells is related to the downregulation of cell cycle-related genes / J.G.Pizarro, M. Yeste-Velasco, J.L. Esparza [et al.] // J.